Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carlos Alarcón Urdaneta"'
Autor:
Olga G. Cantú-Rodríguez, Guillermo J. Ruiz-Delgado, Carlos Alarcón Urdaneta, Guillermo J. Ruiz-Argüelles, Maryel Montes-Montiel, Uxmal Rodriguez-Morales, Omar Eduardo Fernandez-Vargas, Luz Tarín-Arzaga, David Gómez-Almaguer, Jackeline Calderon-García, Mónica Sánchez-Cárdenas
Publikováno v:
Hematology (Amsterdam, Netherlands). 17(4)
Rituximab (R) has changed the prognosis of patients with non-Hodgkin's lymphoma (NHL) in developed countries, but its role has not been analyzed in underprivileged circumstances. One hundred and two patients with NHL treated in a developing country w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ac31e71bc7af8814ee5faa9911052fc
https://pubmed.ncbi.nlm.nih.gov/22889514
https://pubmed.ncbi.nlm.nih.gov/22889514
Autor:
Carlos Alarcón-Urdaneta, Guillermo J. Ruiz-Delgado, David Gómez-Almaguer, Luz Tarín-Arzaga, Guillermo J. Ruiz-Argüelles, Jacqueline Calderón-García
Publikováno v:
Hematology (Amsterdam, Netherlands). 17(3)
Twenty-nine consecutive patients with hairy cell leukemia (HCL) were treated in two institutions with interferon (IFN, n = 18) or cladribine (n = 11), between July 1987 and May 2011. Median age was 62 (range 29-83) years; there were 21 males and 8 fe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b733db86f8d68477bc1e14dfb52aefcd
https://pubmed.ncbi.nlm.nih.gov/22664112
https://pubmed.ncbi.nlm.nih.gov/22664112
Autor:
Carlos Alarcón-Urdaneta, Julia Lutz-Presno, Guillermo J. Ruiz-Delgado, Guillermo J. Ruiz-Argüelles
Publikováno v:
Biology of Blood and Marrow Transplantation. 19:S219
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fba0a776a878d837211eace33eadd111
https://doi.org/10.1016/j.bbmt.2012.11.258
https://doi.org/10.1016/j.bbmt.2012.11.258
Autor:
Omar Eduardo Fernandez-Vargas, Uxmal Rodriguez-Morales, Guillermo J. Ruiz-Argüelles, Luz Tarín-Arzaga, Carlos Alarcón-Urdaneta, David Gomez Almaguer, Olga G. Cantú-Rodríguez, Maryel Montes-Montiel, Jackeline Calderon-García, Guillermo J. Ruiz-Delgado, Mónica Sánchez-Cárdenas
Publikováno v:
Blood. 120:4892-4892
Abstract 4892 Rituximab ( R ) has changed the prognosis of patients with non-Hodgkin′s lymphoma (NHL) in developed countries, but its role has not been analyzed in underprivileged circumstances. One hundred and two patients with NHL treated in a de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d6925d6be811699b1fe10c510c6d7e54
https://doi.org/10.1182/blood.v120.21.4892.4892
https://doi.org/10.1182/blood.v120.21.4892.4892